Deerfield Management Company, L.P. (Series C) Hille Vax, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.76 Billion
- Q2 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Hille Vax, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 4,004,231 shares of HLVX stock, worth $7.05 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
4,004,231
Previous 4,004,231
-0.0%
Holding current value
$7.05 Million
Previous $66.6 Million
13.05%
% of portfolio
1.22%
Previous 1.38%
Shares
6 transactions
Others Institutions Holding HLVX
# of Institutions
93Shares Held
40.5MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$18.7 Million9.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.48MShares$6.13 Million0.03% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.68 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$3.5 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC1.84MShares$3.24 Million3.18% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $58.8M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.